Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BMEA stock hub

Biomea Fusion, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BMEAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
111.3M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
BMEA
In the news

Latest news · BMEA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-152.4
P25 -105.6P50 -46.5P75 -3.1
ROIC-111.1
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BMEA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
183
Groups with data
11
Currency
USD
Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001840439
Company name
Biomea Fusion, Inc.
Country
United States
Country code
US
Cusip
09077A106
Employees
41
Employees Change
-65%
Employees Change Percent
-61.32
Enterprise value
$57.1M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
2021-04-16
Isin
US09077A1060
Last refreshed
2026-05-10
Market cap
$111.3M
Market cap category
Micro-Cap
Price
$1.54
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
BMEA
Website
https://biomeafusion.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-55.5%
FCF yield
-63.2%
P/B ratio
3.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

10
MetricValue
Net Income
$-61.8M
Net Income Growth Quarters
5%
Net Income Growth Years
1%
Profit Per Employee
$-1.5M
ROA
-73.38
Roa5y
-47.96
ROCE
-171.3
ROE
-152.4
Roe5y
-90.76
ROIC
-111.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
Cagr1y
-9.42%
Cagr3y
-63.81%
Cagr5y
-38.1%
EPS Growth Quarters
5
EPS Growth Years
1
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Assets
$58.6M
Cash
$55.8M
Current Assets
$58.1M
Current Liabilities
$11.1M
Debt
$1.6M
Debt Equity
$0.05
Equity
$29.6M
Liabilities
$29M
Long Term Assets
$522,000
Long Term Liabilities
$17.9M
Net Cash
$54.2M
Net Cash By Market Cap
$48.7
Net Cash Growth
9.52%
Net Debt Equity
$-1.83
Tangible Book Value
$29.6M
Tangible Book Value Per Share
$0.41
WACC
2.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
5.23
Net Working Capital
$-7.4M
Quick ratio
5.03
Working Capital
$46.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-44.65%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

40
MetricValue
1Y total return
-9.41%
200-day SMA
1.52
3Y total return
-95.26%
50-day SMA
1.54
50-day SMA vs 200-day SMA
50over200
5Y total return
-90.91%
All Time High
43.69
All Time High Change
-96.48%
All Time High Date
2023-06-08
All Time Low
0.87
All Time Low Change
76.63%
All Time Low Date
2025-11-21
ATR
0.16
Beta
-0.34
Beta1y
2.29
Beta2y
1.78
Ch YTD
24.19
High
1.7
High52
3.08
High52 Date
2025-06-17
High52ch
-50%
Low
1.53
Low52
0.87
Low52 Date
2025-11-21
Low52ch
76.63%
Ma50ch
0.13%
Premarket Change Percent
1.23
Premarket Price
$1.65
Premarket Volume
3,667
Price vs 200-day SMA
1.18%
RSI
46.38
RSI Monthly
39.01
RSI Weekly
49.56
Sharpe ratio
0.45x
Sortino ratio
0.78
Total Return
-44.65%
Tr YTD
24.19
Tr1m
-18.95%
Tr1w
12.41%
Tr3m
26.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

10
MetricValue
Analyst Count
6
Analyst Count Top
2
Analyst Price Target Top
$7
Analyst Ratings
Strong Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$-0.2
Operating Income
$-81.3M
Price target
$8.33
Price Target Change
$441
Price Target Change Top
$355

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
67,444,667%
Float Percent
93.29%
Shares Insiders
6.71%
Shares Institutions
37.9%
Shares Out
72,299,440
Shares Qo Q
19.55%
Shares Yo Y
44.65%
Short Float
20.9%
Short Ratio
7.44
Short Shares
19.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
$-79.9M
Average Volume
1,654,666.2x
Bv Per Share
0.41
Ch1m
-18.95
Ch1w
12.41
Ch1y
-9.41
Ch3m
26.23
Ch3y
-95.26
Ch5y
-90.91
Ch6m
12.41
Change
-5.52%
Change From Open
-4.94
Close
1.63
Days Gap
-0.61
Depreciation Amortization
1,409,000
Dollar Volume
1,677,522
Earnings Date
2026-05-22
Earnings Time
amc
EBIT
$-81.3M
EBITDA
$-79.9M
EPS
$-1.18
F Score
1
FCF
$-70.4M
FCF EV Yield
-123.2x
FCF Per Share
$-0.97
Financing CF
67,904,000
Fiscal Year End
December
Founded
2,017
Ipr
-90.94
Iprfo
-92.3
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-24
Last Report Date
2025-12-31
Last Split Type
Never
Last10k Filing Date
2026-03-24
Ma150
1.42
Ma150ch
8.83%
Ma20
1.74
Ma20ch
-11.29%
Net CF
-2,467,000
Next Earnings Date
2026-05-22
Open
1.62
Optionable
Yes
Position In Range
5.88
Post Close
1.54
Postmarket Change Percent
2.6
Postmarket Price
$1.58
Ppne
153,000
Pre Close
1.63
Price Date
2026-05-08
Ptbv Ratio
3.77
Relative Volume
0.66x
Share Based Comp
9,520,000
Tr6m
12.41%
Us State
California
Volume
1,089,300
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BMEA pay a dividend?

Capital-return profile for this ticker.

Performance

BMEA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-9.4%
S&P 500 1Y: n/a
3Y total return
-95.3%
S&P 500 3Y: n/a
5Y total return
-90.9%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BMEA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+37.9%
Float: +93.3% of shares outstanding
Insider ownership
+6.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+20.9%
7.4 days to cover
Y/Y dilution
+44.7%
Negative means the company is buying back shares.
Technical

BMEA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
46.4
Neutral momentum band
Price vs 200-day MA
+1.2%
50/200-day relationship not available
Beta (5Y)
-0.34
Less volatile than the market
Sharpe ratio
0.45
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BMEA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BMEA stock rating?

Biomea Fusion, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BMEA analysis?

The full report lives at /stocks/BMEA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BMEA?

The latest report frames BMEA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BMEA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.